Audit of manufactured products: Use of allergen advisory labels and identification of labeling ambiguities - 20/08/11
, Danna Chung, MD a, Robert Pacenza, BA b, Todd Slotkin, BS, MBA b, Scott H. Sicherer, MD a
Reprint requests: Mariah M. Pieretti, MD, Department of Pediatrics, Division of Allergy and Immunology, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1198, New York, NY 10029.Abstract |
Background |
The Food Allergy Labeling and Consumer Protection Act became effective January 1, 2006, and mandates disclosure of the 8 major allergens in plain English and as a source of ingredients in the ingredient statement. It does not regulate advisory labels.
Objective |
We sought to determine the frequency and language used in voluntary advisory labels among commercially available products and to identify labeling ambiguities affecting consumers with allergy.
Methods |
Trained surveyors performed a supermarket survey of 20,241 unique manufactured food products (from an original assessment of 49,604 products) for use of advisory labels. A second detailed survey of 744 unique products evaluated additional labeling practices.
Results |
Overall, 17% of 20,241 products surveyed contain advisory labels. Chocolate candy, cookies, and baking mixes were the 3 categories of 24 with the greatest frequency (≥40%). Categorically, advisory warnings included “may contain” (38%), “shared equipment” (33%), and “within plant” (29%). The subsurvey disclosed 25 different types of advisory terminology. Nonspecific terms, such as “natural flavors” and “spices,” were found on 65% of products and were not linked to a specific ingredient for 83% of them. Additional ambiguities included unclear sources of soy (lecithin vs protein), nondisclosure of sources of gelatin and lecithin, and simultaneous disclosure of “contains” and “may contain” for the same allergen, among others.
Conclusion |
Numerous products have advisory labeling and ambiguities that present challenges to consumers with food allergy. Additional allergen labeling regulation could improve safety and quality of life for individuals with food allergy.
Le texte complet de cet article est disponible en PDF.Key words : Food allergy, advisory labeling, quality of life, regulation, FALCPA
Abbreviations used : FALCPA, RMX, UPC
Plan
| Supported by the Food Allergy Initiative, New York. |
|
| Disclosure of potential conflict of interest: S. H. Sicherer serves as a paid consultant for the Food Allergy Initiative, has received research grants from the National Institute of Allergy and Infectious Diseases/the National Institutes of Health, and has served as a medical advisor for the Food Allergy and Anaphylaxis Network. T. Slotkin is Chairman of the Board of Directors of the Food Allergy Initiative. R. Pacenza is Executive Director of the Food Allergy Initiative. The rest of the authors have declared that they have no conflict of interest. |
Vol 124 - N° 2
P. 337-341 - août 2009 Retour au numéro
Article précédent
- Relevance of IgE binding to short peptides for the allergenic activity of food allergens
- Melanie Albrecht, Yvonne Kühne, Barbara K. Ballmer-Weber, Wolf-Meinhard Becker, Thomas Holzhauser, Iris Lauer, Andreas Reuter, Stefanie Randow, Sabine Falk, Andrea Wangorsch, Jonas Lidholm, Gerald Reese, Stefan Vieths
- Defects along the TH17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome
- Shadi Al Khatib, Sevgi Keles, Maria Garcia-Lloret, Elif Karakoc-Aydiner, Ismail Reisli, Hasibe Artac, Yildiz Camcioglu, Haluk Cokugras, Ayper Somer, Necil Kutukculer, Mustafa Yilmaz, Aydan Ikinciogullari, Olcay Yegin, Mutlu Yüksek, Ferah Genel, Ercan Kucukosmanoglu, Ali Baki, Nerin N. Bahceciler, Anupama Rambhatla, Derek W. Nickerson, Sean McGhee, Isil B. Barlan, Talal Chatila
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?